The Cost-Utility of Total Hip Arthroplasty: Earlier Intervention, Improved Economics

Journal of Arthroplasty

Volumn 30, Issue 6, 2015, Pages 945-949

  Lavernia, Carlos J ^a   Iacobelli, David A ^a,b   Brooks, Larry ^b   Villa, Jesus M ^a,b  

^a The Center for Advanced Orthopedics at Larkin Hospital   (United States)

^b Arthritis Surgery Research Foundation   (United States)

Author keywords

Cost effectiveness; Cost utility analysis; Preoperative; QALY; Quality of life; Total hip arthroplasty

Indexed keywords

ADULT; AGE; AGED; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DISEASE SEVERITY; FEMALE; HEALTH CARE COST; HIP OSTEOARTHRITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; QUALITY ADJUSTED LIFE YEAR; REVIEW; SENSITIVITY ANALYSIS; TOTAL HIP PROSTHESIS; WESTERN ONTARIO AND MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX; COST BENEFIT ANALYSIS; ECONOMICS; EPIDEMIOLOGY; HIP ARTHROPLASTY; JOINT DISEASES; MIDDLE AGED; TIME; UNITED STATES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; JOINT DISEASES; MALE; MIDDLE AGED; QUALITY-ADJUSTED LIFE YEARS; TIME FACTORS; UNITED STATES;

EID: 84931576306     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2014.12.028     Document Type: Review

References (33)

1. Soni A., Roemer M. Top five most costly conditions among the elderly, age 65 and older, 2008: estimates for the U.S. civilian noninstitutionalized adult population. Statistical brief #327 2011, Agency for Healthcare Research and Quality, Rockville, MD, [Available at: http://www.meps.ahrq.gov/mepsweb/data_files/publications/st327/stat327.shtml. Accessed Aug 14 2013].
2. Bitton R. The economic burden of osteoarthritis. Am J Manag Care 2009, 15:S230.
3. Mendenhall Associates Inc Hip and knee implant review. Orthop Netw News 2013, 24:1.
4. Kurtz S.M., Ong K.L., Schmier J., et al. Future clinical and economic impact of revision total hip and knee arthroplasty. J Bone Joint Surg Am 2007, 89(Suppl. 3):144.
5. Dijksman L.M., Poolman R.W., Bhandari M., et al. Money matters: what to look for in an economic analysis. Acta Orthop 2008, 79:1.
6. Bozic K.J., Saleh K.J., Rosenberg A.G., et al. Economic evaluation in total hip arthroplasty: analysis and review of the literature. J Arthroplasty 2004, 19:180.
7. Weinstein M.C., Siegel J.E., Gold M.R., et al. Recommendations of the Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996, 276:1253.
8. Russell L.B., Gold M.R., Siegel J.E., et al. The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996, 276:1172.
9. Sutcliffe D., Lester H., Hutton J., et al. NICE and the Quality and Outcomes Framework (QOF) 2009-2011. Qual Prim Care 2012, 20:47.
10. Jenkins P.J., Clement N.D., Hamilton D.F., et al. Predicting the cost-effectiveness of total hip and knee replacement: a health economic analysis. Bone Joint J 2013, 95-B:115.
11. Laupacis A., Bourne R., Rorabeck C., et al. Costs of elective total hip arthroplasty during the first year. Cemented versus noncemented. J Arthroplasty 1994, 9:481.
12. Lavernia C.J., Alcerro J.C. Quality of life and cost-effectiveness 1year after total hip arthroplasty. J Arthroplasty 2011, 26:705.
13. ASA. American Society of Anesthesiologists ASA physical status classification system [Accessed Aug 14, 2013]. http://www.asahq.org/Home/For-Members/Clinical-Information/ASA-Physical-Status-Classification-System.
14. Charlson M.E., Pompei P., Ales K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373.
15. Bellamy N., Buchanan W.W., Goldsmith C.H., et al. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988, 15:1833.
16. Kaplan R.M., Anderson J.P. A general health policy model: update and applications. Health Serv Res 1988, 23:203.
17. Groessl E.J., Kaplan R.M., Cronan T.A. Quality of well-being in older people with osteoarthritis. Arthritis Rheum 2003, 49:23.
18. Social Security Social Security. 2009 Actuarial life table [Accessed Aug 14, 2013]. http://www.ssa.gov/oact/STATS/table4c6.html.
19. Statistics BoL, Bureau of Labor Statistics Consumer price indexes [Accessed Aug 14, 2013]. http://www.bls.gov/cpi/.
20. Rasanen P., Paavolainen P., Sintonen H., et al. Effectiveness of hip or knee replacement surgery in terms of quality-adjusted life years and costs. Acta Orthop 2007, 78:108.
21. Bozic K.J., Rosenberg A.G., Huckman R.S., et al. Economic evaluation in orthopaedics. J Bone Joint Surg Am 2003, 85-A:129.
22. Fryback D.G., Lawrence W.F. Dollars may not buy as many QALYs as we think: a problem with defining quality-of-life adjustments. Med Decis Making 1997, 17:276.
23. Lavernia C.J., Alcerro J.C., Contreras J.S., et al. Patient perceived outcomes after primary hip arthroplasty: does gender matter?. Clin Orthop Relat Res 2011, 469:348.
24. Brauer C.A., Rosen A.B., Olchanski N.V., et al. Cost-utility analyses in orthopaedic surgery. J Bone Joint Surg Am 2005, 87:1253.
25. Chang R.W., Pellisier J.M., Hazen G.B. A cost-effectiveness analysis of total hip arthroplasty for osteoarthritis of the hip. JAMA 1996, 275:858.
26. CMS. Centers for Medicare & Medicaid Services, Local Coverage Determination (LCD) Major joint replacement (hip and knee) (L32078) [Accessed Aug 14, 2013]. http://www.cms.gov/medicare-coverage-database/details/lcd-details.aspx?LCDId=32078&ContrId=195&ver=5&ContrVer=1&CoverageSelection=Both&ArticleType=All&PolicyType=Final&s=Florida&CptHcpcsCode=27130&bc=gAAAABAAAAAAAA%3d%3d&.
27. AAOS Medicare audits 101 [Accessed Feb 7, 2014]. http://www.aaos.org/govern/federal/Medicare/Medicare_Audits_101.asp.
28. Fehring T.K., Fehring K., Odum S.M., et al. Physical therapy mandates by Medicare administrative contractors: effective or wasteful?. J Arthroplasty 2013, 28:1459.
29. Bozic K.J., Stacey B., Berger A., et al. Resource utilization and costs before and after total joint arthroplasty. BMC Health Serv Res 2012, 12:73.
30. Ackerman I.N., Bennell K.L., Osborne R.H. Decline in health-related quality of life reported by more than half of those waiting for joint replacement surgery: a prospective cohort study. BMC Musculoskelet Disord 2011, 12:108.
31. Vergara I., Bilbao A., Gonzalez N., et al. Factors and consequences of waiting times for total hip arthroplasty. Clin Orthop Relat Res 2011, 469:1413.
32. Mota R.E. Cost-effectiveness analysis of early versus late total hip replacement in Italy. Value Health 2013, 16:267.
33. Sadosky A.B., Bushmakin A.G., Cappelleri J.C., et al. Relationship between patient-reported disease severity in osteoarthritis and self-reported pain, function and work productivity. Arthritis Res Ther 2010, 12:R162.